awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q48238170-6AED3AD8-754B-4BF7-B121-098B5DA87912
Q48238170-6AED3AD8-754B-4BF7-B121-098B5DA87912
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48238170-6AED3AD8-754B-4BF7-B121-098B5DA87912
Treatment for patients with relapsed/refractory mantle cell lymphoma: European-based recommendations.
P2860
Q48238170-6AED3AD8-754B-4BF7-B121-098B5DA87912
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48238170-6AED3AD8-754B-4BF7-B121-098B5DA87912
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
966b69ccec3dab314eda98c1b2e8aa8f75d8e0d7
P2860
A phase II study of bortezomib and gemcitabine in relapsed mantle cell lymphoma from the National Cancer Institute of Canada Clinical Trials Group (IND 172).